Agilent Technologies (NYSE:A) Updates FY 2025 Earnings Guidance

Agilent Technologies (NYSE:A) issued an update on its FY 2025 earnings guidance on Wednesday morning. The company provided EPS guidance of 5.540-5.610 for the period, compared to the consensus EPS estimate of 5.570. The company issued revenue guidance of $6.7 billion-$6.8 billion, compared to the consensus revenue estimate of $6.8 billion. Agilent Technologies also updated its Q2 2025 guidance to 1.250-1.280 EPS.

Agilent Technologies Stock Down 0.3 %

NYSE A traded down $0.39 on Friday, hitting $126.70. 612,594 shares of the stock were exchanged, compared to its average volume of 1,693,555. Agilent Technologies has a fifty-two week low of $124.16 and a fifty-two week high of $155.35. The company has a 50-day moving average price of $140.78 and a 200-day moving average price of $139.20. The company has a market cap of $36.14 billion, a PE ratio of 29.12, a PEG ratio of 3.64 and a beta of 1.07. The company has a quick ratio of 1.58, a current ratio of 2.09 and a debt-to-equity ratio of 0.57.

Agilent Technologies (NYSE:A) last posted its earnings results on Wednesday, February 26th. The medical research company reported $1.31 EPS for the quarter, beating the consensus estimate of $1.27 by $0.04. The firm had revenue of $1.68 billion for the quarter, compared to analyst estimates of $1.67 billion. Agilent Technologies had a return on equity of 25.58% and a net margin of 19.27%. Sell-side analysts anticipate that Agilent Technologies will post 5.56 EPS for the current fiscal year.

Agilent Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, April 23rd. Investors of record on Tuesday, April 1st will be paid a dividend of $0.248 per share. This represents a $0.99 annualized dividend and a yield of 0.78%. The ex-dividend date is Tuesday, April 1st. Agilent Technologies’s payout ratio is 22.76%.

Wall Street Analyst Weigh In

A number of analysts have weighed in on A shares. JPMorgan Chase & Co. cut their price objective on shares of Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating on the stock in a report on Tuesday, November 26th. Robert W. Baird cut their price target on shares of Agilent Technologies from $161.00 to $159.00 and set an “outperform” rating on the stock in a research note on Thursday. Barclays upgraded shares of Agilent Technologies from an “underweight” rating to an “equal weight” rating and upped their price objective for the company from $135.00 to $145.00 in a research note on Monday, February 10th. Wells Fargo & Company dropped their price objective on Agilent Technologies from $157.00 to $155.00 and set an “overweight” rating on the stock in a report on Monday, December 9th. Finally, Sanford C. Bernstein reduced their target price on Agilent Technologies from $140.00 to $135.00 and set a “market perform” rating for the company in a report on Tuesday, November 26th. Seven equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $146.15.

Insider Activity at Agilent Technologies

In related news, CEO Padraig Mcdonnell sold 1,911 shares of Agilent Technologies stock in a transaction on Tuesday, January 21st. The shares were sold at an average price of $150.00, for a total value of $286,650.00. Following the transaction, the chief executive officer now directly owns 39,652 shares in the company, valued at $5,947,800. This trade represents a 4.60 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.